- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT03271125
Intensive Multimodal Training for Persons With MS (Treadmill)
Intensive Multimodal Training for Persons With Multiple Sclerosis: Random Controlled Trial
Przegląd badań
Status
Warunki
Interwencja / Leczenie
Szczegółowy opis
Persons with multiple sclerosis can have various deficits, affecting many aspects of physical and cognitive functioning often leading to low levels of physical activity in daily life. These include poor endurance, muscle weakness, incoordination and poor balance and cognitive deficits that can all lead to persistent mobility difficulties in daily life.
Given the importance of exercise and physical activity for persons with multiple sclerosis that are already moderately to severely hampered by their locomotor ability and balance, the setting up of intense functional mobility training that targets the main deficits, in adjunction to a clinical rehabilitation usual care and under close supervision, may be a viable way of increasing the level of physiological health and give a basis for the persons to start their own activity pursuit outside of the rehabilitation clinic. Treadmill walking has several benefits for mobility rehabilitation. First, it is a everyday task, walking. Second it lends itself well to a dual task paradigm where other aspects of mobility, such as equilibrium and cognitive factors can be addressed during walking. Third, even persons with severe walking limitations can train walking at various speeds when on treadmill, holding onto handrails and using safety harnesses that minimize the possibility of adverse events during training. Further, the treadmill paradigm lends itself well to training with progressive task difficulty, numerous rhythmic repetitions, and importantly it can include an aerobic component to improve cardiorespiratory fitness. All of which should lead to improved submaximal exercise tolerance and endurance, more functional mobility and consequently increased ability to carry out activities of daily living.
Methods: A consecutive sample of 42 People with Multiple Sclerosis (PwMS) were recruited from the outpatient/inpatient rehabilitation service of the Don Gnocchi Foundation. The study was conducted in accordance with the Declaration of Helsinki and was approved by the ethics committee of the Don Gnocchi Foundation. Subjects signed an informed consent form before the beginning of the study.
The study design was a two arm randomized 2:1 controlled trial (see study flow chart in Figure 1).
The participants were assessed before and after the rehabilitation period by researchers blinded to group assignment.
Participants in both groups received 15- 20 treatments sessions lasting 30 minutes 5 times per week by experienced physical therapists trained for the study. All participants also followed their usual rehabilitation care protocols as planned.
Typ studiów
Zapisy (Rzeczywisty)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Lokalizacje studiów
-
-
MI
-
Milan, MI, Włochy, 20148
- Fondazione Don Carlo Gnocchi IRCCS
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
- Diagnosis of multiple sclerosis according to McDonald's criteria (Polman et al. Ann Neurology 2011)
- EDSS score <= 7
- Free from relapses and steroid treatment for at least 1 month)
- Able to stand 30 seconds,
- Able to walk at least 10 meters independently or with a cane
- Able to understand and follow instructions
- Stable neurological conditions and willingness to participate in the study.
Exclusion Criteria:
- Cardiac pacemaker
- Any pre-existing conditions that affected walking function
- diagnosis of depression or psychotic disorder
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Leczenie
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Pojedynczy
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
---|---|
Eksperymentalny: Treadmill group
Participants in the experimental group received supervised treadmill training
|
Participants in the experimental group received supervised treadmill training, 4-5 sessions per week.
The treatment protocol was aimed at improving participants' resistance, walking velocity, balance and cognitive functions during motor and cognitive (dual) tasks.
The treadmill training was carried out without body weight support but if needed the participants were attached to a safety harness.
|
Aktywny komparator: Resistance group
Participants in the control group were treated with Resistance exercises.
|
Participants in the control group were treated with Resistance exercises, 4-5 sessions per week.
The treatment protocol was aimed at improving strength in muscles involved in walking (hip abductors, quadriceps, plantar flexors, dorsal flexors) according to current guidelines from the American College of Sports Medicine (2009).
Three sets of 10 repetitions were performed bilaterally with appropriate weights for each exercise
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
Two minute walking test
Ramy czasowe: Two minutes
|
The subjects were instructed to walk at their usual speed for 2 minutes while the distance they covered in 2 minutes was recorded in meters.
|
Two minutes
|
Timed up and go test
Ramy czasowe: 1 minute
|
The Timed Up & Go test (TUG) is a simple functional test that requires a person to stand up, walk 3m, turn back, and sit down again while being timed.
|
1 minute
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
The Frontal Assessment Battery
Ramy czasowe: 10 minutes
|
The Frontal Assessment Battery (FAB) is a short cognitive and behavioral six-subtest battery for the bedside screening of a global executive dysfunction.
|
10 minutes
|
Ten meter walking test
Ramy czasowe: 2 minutes
|
The 10 meters walking test (10MWT) is a test in which the participant is timed while walking 10m at their comfortable speed.
|
2 minutes
|
The Berg Balance Scale
Ramy czasowe: 15 minutes
|
The Berg Balance Scale (BBS) is a 14-item scale widely used to assess balance disorders in PwMS.
BBS provides information about patient's balance-related abilities.
|
15 minutes
|
Dynamic Gait Index
Ramy czasowe: 15 minutes
|
The Dynamic Gait Index (DGI) measures gait function and dynamic balance.
The eight tasks of this scale include walking, walking with head turns, pivoting, walking over objects, walking around objects, and going upstairs.
|
15 minutes
|
The Short Form-12 questionnaire (SF-12)
Ramy czasowe: 10 minutes
|
The SF12 is comprised of two domains, physical and mental and gives two composite scores that reflect the perceived health of the participant.
|
10 minutes
|
Współpracownicy i badacze
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Rzeczywisty)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- Treadmill MS
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Opis planu IPD
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .
Badania kliniczne na Stwardnienie rozsiane
-
Teva Branded Pharmaceutical Products R&D, Inc.ZakończonyRelapse Remiting Sclerosis Multiplex
-
Novartis PharmaceuticalsAktywny, nie rekrutującyRelapse Remiting Sclerosis MultiplexStany Zjednoczone, Portoryko
-
Teva Branded Pharmaceutical Products R&D, Inc.ZakończonyRelapse Remiting Sclerosis Multiplex
-
Thomas Jefferson UniversityRekrutacyjnyRelapse Remiting Sclerosis MultiplexStany Zjednoczone
-
Novartis PharmaceuticalsZakończonyRelapse Remiting Sclerosis MultiplexStany Zjednoczone, Ukraina, Czechy
-
Thomas Jefferson UniversityRekrutacyjnyRelapse Remiting Sclerosis MultiplexStany Zjednoczone
Badania kliniczne na Treadmill
-
Assaf-Harofeh Medical CenterBen-Gurion University of the NegevNieznanyPorażenie mózgowe (CP)Izrael